Details
Category: Volume 06 Issue 08 August 2018
Hits: 1045

Title: Clinical and Hormonal Profile in Non Obese Women of Polycystic Ovarian Syndrome

Authors: Dr Jyoti Bindal, Dr Renu Jain

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i8.74

Abstract

Background: Polycystic ovary syndrome (PCOS) is a complex syndrome showing the clinical features of an endocrine/ metabolic disorder, including hyperinsulinemia and hyperandrogenism.  Two phenotypes are present, either lean or obese, with different biochemical, hormonal, and metabolic profiles. The objective of present study was to analyze the clinical presentation and its correlation with hormonal profile in non obese women with polycystic ovary syndrome (PCOS).

Material and Methods: This prospective study was carried out on 70 non obese PCOS women (BMI < 25 kg/m2), diagnosed on the basis of Rotterdam’s criteria, in department of Obstetrics and Gynaecology, Gajra Raja Medical College, Gwalior (M.P.). The data of the anthropometric measurements, clinical manifestations of hyperandrogenism, serum levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and total testosterone were collected and ultrasonography was done.

Results: Maximum number of cases (34.28%) were in age group 26-30 years. Menstrual irregularity was the most common complaint in 80% women. 54.28% women were hirsute. Serum LH and serum total testosterone were raised in 68.56% and 65.71% women, respectively. Mean serum testosterone was 2.5 ± 0.4. The most common phenotype was phenotype A (55.71%).PCOS women with hirsutism had raised LH:FSH ratio in 41.02% group A, in 58.33% group B and in 50 % group Cwomen, as compared to only 20% women in group D had raised LH:FSH ratio.

Conclusion: The patients with PCOS, irrespective of their weight, demonstrate clinical manifestations such as irregular cycles, acne, hirsutism; hormonal abnormalities such as higher LH, LH/FSH, and testosterone levels.

Keywords: Polycystic ovarian syndrome (PCOS), hyperandrogenism, Rotterdam’s criteria.

References

  1. Schorge JO, Schaffer JI, Halvorson LM, Hoffman BL, Bradshow KD, Cunningham FG. Polycystic Ovarian Syndrome and hyperandrogenism. In: Editors, William’s Gynaecology. 1st New York: McGraw Hill Medical; 2008.p.383-401.
  2. Franks S, Gharani N, Waterworth D, Batty S, White D et al. The genetic basis of polycystic ovary syndrome. Hum Reprod. 1997 Dec (12); 12: 2641-8.
  3. Goyal M, Dawood AS. Debates regarding lean patients with polycystic ovary syndrome: A narrative review. J Hum Reprod Sci. 2017 July-Sept; 10 (3): 154-161.
  4. The Rotterdam ESHRE / ASRM- sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004: 19: 41-7.     
  5. Saxena P, Prakash A, Nigam A, Mishra A. PCOS: is obesity a sine qua non? a clinical, hormonal, and metabolic assessment in relation to BMI. Indian J Endocrinol Metab. 2012;16(6):996-9.
  6. Gupta N, Radhakrishnan G, Madhu SV, Radhika G. Comparison of metabolic and endocrinal parameters in obese and nonobese women of polysystic ovarian syndrome with normal controls. Fertil Sci Res. 2015; 2: 19-23.
  7. Akshaya S, Bhattacharya R. Comparative study of clinical profile of lean and obese polycystic ovary syndrome women. Int J Reprod Contracept Obstet Gynecol 2016;5:2530-3.
  8. Majumdar A, Singh TA. Comparison of clinical features and health manifestation in lean vs obese women with polycystic ovary syndrome. Endocr Abstr 2006;11:341.
  9. Sakina S, Rashid F,Rizvi M, Ulabeer S, Ashraf S. Comparative analysis of the clinical, biochemical and hormonal profile of obese versus lean Kashmiri PCOS patients – A pilot study. International Journal of Advances in Science, Enineering and Technology. 2017 April; 5 (2): 55-60.
  10. Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab. 2003; 88:4682–4688.
  11. Ramanand SJ, Ghongane BB, Ramanand BJ, Patwardhan HM, Patwardhan VM. Hormonal profile of polycystic ovary syndrome ( PCOS ) in Indian women. RJPBCS. 2012 Dec; 3 ( 4 ): 1159.
  12. Dewailly D, Catteau-Jonard S, Reyss A-C, Leroy M, Pigny P. Oligoanovulation with polycystic ovaries but not overt hyperandr-ogenism. Journal of Clinical Endocrinolgy and Metabolism. 2006;91(10):3922–3927.
  13. Welt CK, Gudmundsson JA, Arason G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism. 2006;91(12):4842–4848.
  14. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA  et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999 Nov; 84 (11): 4006-11.

Corresponding Author

Dr Renu Jain

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.